Genomic Analysis of Pediatric Bone Tumors

Stanford University

Status: Completed

Conditions: Bone Cancer

Study type: Observational

Funder types: Other

Identifiers

NCT01047878

PEDSSARC0001

SU-12082009-4522 (Other Identifier)

97630 (Other Identifier)

Details and patient eligibility

About

To determine whether gene expression analysis of primary tumor samples before and after chemotherapy are predictive of long-term survival in pediatric patients with bone sarcomas (Ewings sarcoma (ES) and Osteosarcoma(OS)).

Enrollment: 163 patients

Sex: All

Ages: Under 18 years old

Volunteers: No Healthy Volunteers

Inclusion and exclusion criteria

Inclusion Criteria:All patients with bone x-rays suggestive of a malignant bone tumor Exclusion Criteria:Patients with a known diagnosis of cancer.